Weill Cornell Initiative for Maximizing Student Development
Weill Cornell Initiative for Maximizing Student Development
批准号:
10618368
负责人:
ETHEL CESARMAN
金额:
$51.8万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-05-01 至 2025-04-30
关键词:
AddressBiomedical ResearchCareer ChoiceCareer ExplorationCommunitiesCommunity Health EducationCommunity NetworksDevelopmentDevelopment PlansDoctor of PhilosophyEducational CurriculumEducational process of instructingEthnic OriginEventFacultyFosteringFundingGoalsHealthIndividualInstitutionInterventionInterviewLaboratoriesLeadershipLifeMeasuresMedicineMemorial Sloan-Kettering Cancer CenterMentorsMentorshipMinority-Serving InstitutionNew York CityOutcomePerformancePreparationQualifyingRaceReadinessResearchResourcesSchoolsScienceSelf EfficacySliceStreamStudentsTrainingTraining and EducationUnderrepresented MinorityUnderrepresented Populationsbiomedical scientistcareercareer developmentcourse developmentdesigndoctoral studentexternshipgraduate schoolgraduate school preparationhealth care disparityhigher educationinnovationleadership developmentmatriculationmembernext generationprogramsrecruitself-renewalskillssocialsymposiumsystemic barriertoolunderrepresented minority student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
The Weill Cornell Graduate School (WCGS)—an educational and training partnership between Weill Cornell
Medicine and Memorial Sloan Kettering Cancer Center—is a premier institution for PhD training in the
biomedical sciences. We look to leverage our training capacity ($275 million in research funding, 340 graduate
school faculty, and over 330 PhD students) to increase our rates of attracting, retaining, and developing
underrepresented minority (URM) doctoral students as leaders in the biomedical workforce. To accomplish this
goal, we propose a Weill Cornell IMSD program with the following aims: (1) Attract a pool of well-prepared
URM students to WCGS through partnerships with local and minority-serving institutions; (2) Build a robust,
self-renewing community of URM doctoral students and faculty through an early start program, multifaceted
mentorship, and social gatherings; and (3) Equip IMSD scholars with leadership training, professional skills
and networks to be leaders in a variety of biomedical and science-related careers. WCGS is primed for training
the next generation of URM biomedical scientists and we are confident that through the Weill Cornell IMSD, we
can develop a steady stream of well-trained PhD's that will both diversify and bring innovation to the
biomedical workforce.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)
-
批准号:10592130
-
项目类别:
-
资助金额:$44.89万
-
财政年份:2023
-
负责人:ETHEL CESARMAN
-
依托单位:
Next-Gen Oncopathology Program
-
批准号:10676213
-
项目类别:
-
资助金额:$36.18万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
Rapid Sample-to-Answer Diagnosis of Kaposi's Sarcoma Across Sub-Saharan Africa using KS-COMPLETE
-
批准号:10416778
-
项目类别:
-
资助金额:$65.74万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
Rapid Sample-to-Answer Diagnosis of Kaposi's Sarcoma Across Sub-Saharan Africa using KS-COMPLETE
-
批准号:10642906
-
项目类别:
-
资助金额:$61.26万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
B cell determinants of EBV latency
-
批准号:10541734
-
项目类别:
-
资助金额:$86.4万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
B cell determinants of EBV latency
-
批准号:10701826
-
项目类别:
-
资助金额:$82.78万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
-
批准号:10228431
-
项目类别:
-
资助金额:$120.03万
-
财政年份:2021
-
负责人:ETHEL CESARMAN
-
依托单位:
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
-
批准号:10616708
-
项目类别:
-
资助金额:$117.81万
-
财政年份:2021
-
负责人:ETHEL CESARMAN
-
依托单位:
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
-
批准号:10398963
-
项目类别:
-
资助金额:$117.86万
-
财政年份:2021
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10737765
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10397107
-
项目类别:
-
资助金额:$41.69万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10532587
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10617688
-
项目类别:
-
资助金额:$41.69万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10165675
-
项目类别:
-
资助金额:$41.69万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
Weill Cornell Initiative for Maximizing Student Development
-
批准号:10405468
-
项目类别:
-
资助金额:$51.8万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
Weill Cornell Initiative for Maximizing Student Development
-
批准号:9893726
-
项目类别:
-
资助金额:$51.8万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
Role of novel onco-histone mutations in B-cell malignancies
-
批准号:10671507
-
项目类别:
-
资助金额:$65.16万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
Role of novel onco-histone mutations in B-cell malignancies
-
批准号:10454959
-
项目类别:
-
资助金额:$65.16万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
The 22nd International Conference on Kaposi's sarcoma-associated herpesvirus and Related Agents
-
批准号:9763269
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
Targeting vFLIP for the treatment of KSHV-associated malignancies
-
批准号:8433482
-
项目类别:
-
资助金额:$32.96万
-
财政年份:2011
-
负责人:ETHEL CESARMAN
-
依托单位:
海外基金